|
|
|
|
|
|
Science
Kleanthis Xanthopoulus is president and CEO of Carlsbad's Regulus Therapeutics, which is working extensively with RNA-based therapies. Read the whole story here. Photo: Sam Hodgson
A group of UCSD researchers are among the leaders in a worldwide effort to understand why honeybees are disappearing at an unprecedented rate. They have honed in on a common pesticide as a possible culprit.
» By REBECCA TOLIN | Nov 8
Big Pharma has largely bailed on the battle against deadly antibiotic-resistant bacteria, leaving the dire public health threat in the hands of small biotechs.
|
Pfizer's latest restructuring shows how another large pharmaceutical company's cutbacks on in-house R&D could be good for San Diego's small biotechs.
A nonprofit incubator for start-up companies is the latest in a line of innovations that have risen from the economic wreckage of the past year.
Contributing Voices
Problems at the U.S. Patent Office reverberate in San Diego, as increased costs for patents impact innovation.
» By William E. Hunter | Aug 21
|
One of the chosen few companies in the EvoNexus incubator addresses the issue of medication errors in hospitals. Nov. 11 -- 2:57 pm
|
|
|
|
|
|
|
|
Copyright © 2009 voiceofsandiego.org. All Rights Reserved.
|
an independent nonprofit |
Delays in Patent Reform a Detriment to SD Economy
